CVC, Bain Among Bidders in $3B Curium Pharma Sale

CVC Capital Partners and Bain Capital are among buyout firms that submitted initial bids for Curium Pharma, a French maker of medical imaging supplies, people familiar with the matter said. Clayton Dubilier & Rice, Nordic Capital and PAI Partners also made first-round offers for the business, which is owned by CapVest Ltd., according to the people. Curium could fetch at least $3 billion, the people said, asking not to be identified because the information is private. Management presentations are taking place this week, and the company expects to receive the next round of bids in February, the people said. Curium provides materials used in nuclear medicine to help diagnose cancer as well as heart, brain and bone diseases. The company was created by merging IBA Molecular with a Mallinckrodt Plc business in 2017.

Read the full article: CVC, Bain Among Bidders in $3B Curium Pharma Sale //


Scroll to Top